Biogen Inc’s recent filing unveils that its Officer Izzar Rachid acquired Company’s shares for reported $0.3 million on Jul 08 ’25. In the deal valued at $135.00 per share,2,223 shares were bought.
Then, Singhal Priya sold 3,806 shares, generating $480,508 in total proceeds. Upon selling the shares at $126.25, the Head of Development now owns 5,427 shares.
Before that, Singhal Priya bought 3,806 shares. Biogen Inc shares valued at $480,508 were divested by the Officer at a price of $126.25 per share.
HSBC Securities downgraded its Biogen Inc [BIIB] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Argus’s analysts, who decreased its forecast for the stock in early April from “a Buy” to “a Hold”. Bernstein began covering BIIB with “Mkt perform” recommendation on February 11, 2025. Piper Sandler revised its rating on January 02, 2025. It rated BIIB as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of BIIB
On Friday, Biogen Inc [NASDAQ:BIIB] saw its stock fall -0.83% to $134.21. Over the last five days, the stock has gained 1.01%. Biogen Inc shares have fallen nearly -41.41% since the year began. Nevertheless, the stocks have fallen -12.24% over the past one year. While a 52-week high of $238.00 was reached on 03/10/25, a 52-week low of $110.04 was recorded on 04/09/25.
Levels Of Support And Resistance For BIIB Stock
The 24-hour chart illustrates a support level at 132.86, which if violated will result in even more drops to 131.50. On the upside, there is a resistance level at 135.08. A further resistance level may holdings at 135.94.
How much short interest is there in Biogen Inc?
A steep rise in short interest was recorded in Biogen Inc stocks on 2025-06-13, growing by 49637.0 shares to a total of 3.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 3.34 million shares. There was a rise of 1.46%, which implies that there is a positive sentiment for the stock.
